Extended Data Fig. 3: In vitro responsiveness of leukemia cells to five compounds in order of elimination efficacy of S63845, barasertib and GSK923295. | Nature Cancer

Extended Data Fig. 3: In vitro responsiveness of leukemia cells to five compounds in order of elimination efficacy of S63845, barasertib and GSK923295.

From: Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia

Extended Data Fig. 3

AML cases are arranged in the order of responsiveness to a, S63845, b, barasertib and c, GSK923295. Information on selected somatic mutations and chromosome abnormalities are shown below (n = 66).

Source data

Back to article page